phase
male
holstein
calv
risk
bovin
respiratori
diseas
initi
age
singl
dairi
farm
transport
h
southwest
ohio
calv
randomli
assign
receiv
sc
inject
draxxin
mg
tulathromycinkg
bw
zoeti
florham
park
nj
tul
arriv
wean
receiv
inject
con
milk
replac
fed
kg
dm
daili
kg
dm
daili
highgrain
textur
starter
water
fed
free
choic
first
phase
phase
calv
phase
group
con
tul
move
group
pen
pen
per
treatment
calv
per
pen
next
starter
phase
blend
chop
grass
hay
fed
free
choic
phase
postwean
starter
intak
bw
gain
overal
bw
gain
final
bw
greater
tul
con
medic
treatment
differ
phase
dmi
bw
greater
con
tul
calf
bw
gain
final
bw
feed
effici
hip
width
chang
greater
tul
con
phase
tul
calv
gain
kg
bw
vs
kg
cm
hip
width
vs
cm
con
calv
tul
improv
calf
health
approxim
dairi
calv
die
calf
morbid
signific
issu
usdaaphi
although
primari
reason
morbid
mortal
prewean
dairi
calf
typic
enter
bovin
respiratori
diseas
brd
signific
concern
calv
mo
age
svensson
et
al
primari
caus
mortal
wean
averag
usdaaphi
brd
primari
caus
calf
death
metaphylact
antibiot
treatment
wean
beef
dairi
calv
implement
mani
farm
usdaaphi
draxxin
mgml
tulathromycin
zoeti
florham
park
nj
approv
control
brd
beef
cattl
nonlact
dairi
cattl
includ
dairi
calv
veal
calv
high
risk
develop
brd
associ
mannheimia
haemolytica
pasteurella
multocida
histophilu
somni
mycoplasma
bovi
although
govern
agenc
encourag
less
use
antibiot
livestock
wees
et
al
metaphylact
use
tulathromycin
commingl
dairi
calv
report
lower
incid
diarrhea
otiti
media
brd
improv
growth
stanton
et
al
stanton
et
al
stanton
et
al
suggest
possibl
reduc
antibiot
resist
wees
calv
mo
age
metaphylact
treat
tul
approxim
age
tul
increas
adg
reduc
incid
diarrhea
otiti
media
stanton
et
al
calv
metaphylact
treat
tul
versu
oxytetracyclin
approxim
mo
age
adg
wither
height
chang
increas
approxim
mo
age
calv
treat
diseas
incid
respiratori
infect
reduc
stanton
et
al
stanton
et
al
peerreview
research
tul
young
dairi
calv
found
use
tul
reduc
risk
morbid
mortal
dairi
calv
observ
stanton
et
al
stanton
et
al
stanton
et
al
therefor
object
test
metaphylact
use
tul
prewean
dairi
calv
evalu
carryov
effect
wean
implement
studi
period
approxim
mo
treat
approxim
calv
brd
untyp
high
rate
research
unit
calv
care
accept
practic
describ
guid
care
use
agricultur
anim
agricultur
research
teach
fass
phase
group
male
holstein
calv
total
initi
age
singl
dairi
farm
transport
h
nurtur
research
center
southwest
ohio
second
group
arriv
first
group
upon
arriv
calv
randomli
assign
receiv
sc
inject
draxxin
mg
tulathromycinkg
bw
tul
arriv
wean
receiv
inject
con
calv
hous
individu
pen
coarserock
tiledrain
floor
bed
straw
curtainsid
natur
ventil
barn
ad
heat
milk
replac
mr
fed
kg
dm
daili
kg
dm
daili
mr
manufactur
whey
whey
protein
concentr
anim
fat
cp
fat
tabl
reconstitut
solid
warm
water
fed
h
daili
highgrain
textur
starter
tabl
fed
approxim
h
water
fed
approxim
h
fed
free
choic
phase
everi
bag
mr
starter
sampl
composit
nutrient
analysi
manag
practic
includ
vaccin
medic
treatment
trial
base
recommend
herd
veterinarian
day
arriv
approxim
noon
approxim
h
feed
mr
calv
weigh
initi
bw
time
blood
sampl
intraven
serum
separ
centrifug
g
vwr
batavia
il
min
serum
protein
concentr
estim
use
optic
refractomet
atago
usa
inc
bellevu
wa
calv
weigh
initi
weekli
thereaft
approxim
noon
bodi
condit
score
thin
obes
modifi
wildman
et
al
hip
width
use
calip
measur
initi
everi
wk
thereaft
phase
conduct
consecut
month
octob
januari
averag
temperatur
nurseri
rang
averag
rel
humid
rang
fece
score
daili
use
scale
normal
wateri
modifi
kertz
chesterjon
calv
fecal
score
greater
consid
abnorm
fecal
score
receiv
oral
electrolyt
count
medic
treatment
first
first
abnorm
fece
fecal
score
greater
per
calf
sampl
mix
aliquot
test
cryptosporidium
rotaviru
coronaviru
escherichia
coli
use
later
immunochromatographi
strip
biox
diagnost
jemel
belgium
antibiot
medic
treatment
record
daili
bovin
respiratori
diseas
defin
one
follow
symptom
cough
nasal
discharg
labor
breath
rectal
temperatur
baytril
bayer
healthcar
shawne
mission
ks
ml
sc
administ
calv
brd
banamin
merck
madison
nj
ml
iv
administ
lethargi
navel
infect
treat
ml
penicillin
g
procain
im
unitsml
agri
laboratori
ltd
st
joseph
mo
daili
experienc
technician
auscult
lung
calv
right
anterior
side
calv
assist
identif
respiratori
diseas
calv
receiv
intranas
respiratori
diseas
vaccin
zoeti
parsippani
nj
sc
inject
vitamin
e
vital
e
merck
anim
health
se
muse
merck
anim
health
upon
arriv
calv
receiv
inject
bovashield
gold
zoeti
calv
surgic
castrat
dehorn
age
phase
calv
phase
group
con
tul
move
group
pen
pen
per
treatment
calv
per
pen
next
pen
outsid
pen
space
insid
pen
space
per
calf
insid
pen
space
bed
straw
ad
heat
starter
fed
phase
blend
chop
grass
hay
tabl
starterforag
mix
water
fed
free
choic
everi
bag
starter
everi
bale
hay
sampl
composit
nutrient
analysi
initi
calv
weigh
score
bodi
condit
hip
width
measur
trial
conduct
consecut
month
decemb
march
immedi
follow
phase
group
calv
averag
temperatur
phase
rang
averag
rel
humid
rang
composit
feed
refus
feed
analyz
aoac
intern
dm
oven
method
ash
oven
method
cp
kjeldahl
method
fat
alkalin
treatment
roesegottlieb
method
mr
diethyl
ether
extract
method
starter
hay
ndf
ash
procedur
van
soest
et
al
without
sodium
sulfit
adf
ash
robertson
van
soest
starch
method
hall
sugar
colormetr
method
duboi
et
al
nutrient
analysi
refus
feed
wk
pen
similar
composit
feed
offer
phase
data
first
group
week
except
hip
width
bc
chang
group
period
data
analyz
complet
random
block
design
repeat
measur
applic
proc
mix
sa
version
sa
institut
inc
cari
nc
calf
group
receiv
apart
block
autoregress
type
covari
matrix
employ
determin
use
akaik
inform
criteria
abnorm
fecal
score
day
medic
day
sum
phase
analyz
use
kruskalw
test
proc
sa
calf
calf
per
pen
experiment
unit
phase
intak
growth
data
analyz
complet
random
block
design
repeat
measur
applic
group
two
period
bodi
measur
proc
mix
sa
autoregress
type
covari
matrix
employ
determin
use
akaik
inform
criteria
pen
experiment
unit
signific
determin
p
trend
consid
p
initi
measur
phase
differ
tabl
prewean
measur
differ
postwean
starter
intak
vs
kgd
adg
vs
kgd
greater
p
tul
con
overal
adg
vs
kgd
final
bw
vs
kg
greater
p
tul
con
medic
treatment
differ
con
calv
treat
navel
infect
calv
treat
brd
symptom
nasal
discharg
fever
lethargi
tul
calv
treat
navel
infect
calf
treat
brd
symptom
nasal
discharg
navel
infect
identifi
treatment
began
abnorm
breath
sound
detect
auscult
abnorm
fecal
score
also
differ
fecal
sampl
calv
abnorm
fece
test
posit
cryptosporidium
rotaviru
phase
dmi
differ
howev
dmi
percentag
bw
vs
bw
greater
p
con
tul
tabl
calf
adg
vs
kgd
final
bw
vs
kg
feed
effici
vs
g
f
hip
width
chang
vs
cm
greater
p
tul
con
phase
differ
bw
kg
bw
kg
tul
kg
con
cm
hip
width
chang
cm
tul
cm
con
stressor
trigger
diseas
calv
effect
cortisol
variou
cytokin
stressor
occur
frequent
first
mo
life
hulbert
signific
stressor
life
calf
includ
castrat
dehorn
wean
commingl
vaccin
hulbert
stressor
frequent
occur
wk
age
respiratori
diseas
preval
stressor
combin
presenc
virus
allow
bacteri
colon
lung
typic
reason
onset
respiratori
diseas
yate
common
outcom
brd
calv
decreas
weight
gain
wither
height
inde
stanton
et
al
show
calv
develop
brd
wk
age
experienc
decreas
weight
gain
wither
height
detect
difficult
critic
treatment
recoveri
diseas
affect
perform
later
life
demonstr
studi
holstein
calv
identif
treatment
diseas
mo
age
improv
firstand
subsequentlact
milk
product
heinrich
heinrich
calv
current
trial
face
mani
stressor
includ
transport
birth
farm
research
facil
sever
vaccin
castrat
dehorn
wean
commingl
trial
calv
appear
healthi
base
ill
identifi
navel
infect
predomin
ill
identifi
infect
evenli
distribut
con
tul
calv
one
calf
navel
infect
iodinestain
hair
around
navel
calv
without
navel
infect
thu
sourcefarm
personnel
like
properli
dip
navel
birth
studi
stanton
et
al
stanton
et
al
stanton
et
al
calv
previous
treat
respiratori
diseas
decreas
growth
increas
mortal
rate
later
life
calv
treat
respiratori
diseas
stanton
et
al
compar
metaphylact
treatment
tul
approxim
age
treatment
report
calv
treat
tul
lower
incid
diarrhea
otiti
media
approxim
increas
bw
gain
kgd
mo
age
stanton
et
al
stanton
et
al
report
adg
height
gain
alter
tul
versu
oxytetracyclin
treatment
approxim
mo
age
calv
respiratori
diseas
approxim
mo
age
howev
calv
without
diseas
adg
kgd
wither
height
gain
cmd
increas
tul
versu
oxytetracyclin
metaphylact
treatment
improv
bw
gain
hip
width
gain
tul
con
consist
report
stanton
et
al
stanton
et
al
stanton
et
al
follow
group
calv
studi
mo
age
found
calv
never
treat
respiratori
diseas
maintain
heavier
bw
mo
age
treat
metaphylact
tul
versu
oxytetracyclin
howev
effect
tul
wither
height
growth
approxim
mo
age
uncertain
wither
height
calv
healthi
sick
greater
mo
tul
versu
oxytetracyclin
treatment
stanton
et
al
stanton
et
al
attribut
improv
growth
reduct
diseas
calv
studi
identif
diseas
low
specul
level
brd
identifi
tul
may
reduc
subclin
diseas
allow
bw
structur
growth
trial
healthi
calv
gain
approxim
bw
hip
width
mo
age
trial
stanton
et
al
stanton
et
al
stanton
et
al
healthi
calv
experienc
improv
bw
structur
growth
first
mo
age
metaphylact
administ
tul
growth
experienc
first
mo
life
appear
maintain
approxim
mo
age
studi
stanton
et
al
calv
appear
healthi
medic
treatment
con
low
medic
treatment
diseas
affect
metaphylact
treatment
dairi
calv
draxxin
mg
tulathromycinkg
bw
near
birth
approxim
age
later
wean
increas
bw
hip
width
gain
approxim
mo
age
gener
calv
trial
healthi
calv
treat
respiratori
enter
diseas
tabl
perform
calv
pen
per
treatment
calv
per
pen
phase
treat
con
treat
tul
draxxin
mg
tulathromycinkg
bw
near
birth
wean
apart
